GL1X · GenesisL1 explorer

Research workbench

Crystal structure of single domain vl of an anti-DNA binding antibody 3D8 scfv and its active site revealed by complex structures of a small molecule and metals

Analyse Crystal structure of single domain vl of an anti-DNA binding antibody 3D8 scfv… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BD3
Type
protein
Length
224 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Catalytic antibody
Pockets
1 · best druggability 0.29

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCatalytic antibodyprotein1123% helix, 51% strand—

Ligands and binding sites

  • BTB · 2-[bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.290.7417empty

Interfaces

1 interface between chains.

  • A–B · 621 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3BD3 · Crystal structure of single domain VL of an anti-DNA binding antibody 3D8 scFv and its… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.